Skip to content
value.today

Halda Therapeutics, LLC

Total raised
$198 M
4 rounds on record
Latest round
$126 M
Jul 2024
First round on record
Feb 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Halda Therapeutics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$126 MNo. 4$50 to $250 million

Halda Therapeutics, LLC: Raise no. 4, Jul 2024

Investors in this round

20 investors had bought by the notice of Aug 12, 2024: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$126 M of $126 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Scott Phillips · Executive Officer
  • Tim Shannon · Executive Officer, Director · Manager
  • Arjun Goyal · Director · Manager
  • Joe Cabral · Director · Manager
  • Liam Ratcliffe · Director · Manager
  • Nandita Shangari · Director · Manager
  • Rebecca Frey · Director · Manager
  • Rebecca Luse · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No amounts other than ordinary course employment compensation is being paid to officers and managers.”

Signed by Scott Phillips, Chief Financial Officer. Newest notice filed Aug 12, 2024. Read the notice at the SEC.

equitySEC
May 2024$24 MNo. 3$10 to $50 million

Halda Therapeutics, LLC: Raise no. 3, May 2024

Investors in this round

9 investors had bought by the notice of May 24, 2024: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $36 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Scott Phillips · Executive Officer
  • Tim Shannon · Executive Officer, Director · Manager
  • Liam Ratcliffe · Director · Manager
  • Rebecca Frey · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No amounts other than ordinary course employment compensation is being paid to officers and managers.”

Signed by Scott Phillips, Chief Financial Officer. Newest notice filed May 24, 2024. Read the notice at the SEC.

debt, optionsSEC
Dec 2021$41 MNo. 2$10 to $50 million

Halda Therapeutics, LLC: Raise no. 2, Dec 2021

Investors in this round

11 investors had bought by the notice of Dec 10, 2021: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$41 M of $51 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Scott Phillips · Executive Officer
  • Tim Shannon · Executive Officer, Director · Manager
  • Leyi Wang · Director · Manager
  • Liam Ratcliffe · Director · Manager
  • Rebecca Frey · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No amounts other than ordinary course employment compensation is being paid to officers and managers.”

Signed by Scott Phillips, Treasurer and Secretary. Newest notice filed Dec 10, 2021. Read the notice at the SEC.

equitySEC
Feb 2019$6 MNo. 1$2 to $10 million

Halda Therapeutics, LLC: Raise no. 1, Feb 2019

Investors in this round

12 investors had bought by the notice of Mar 1, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $25 M offered; $19 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Scott Phillips · Executive Officer
  • Tim Shannon · Executive Officer, Director · Manager
  • Wei Zhao · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No payments other than ordinary course employment compensation is being paid to officers and managers.”

Signed by Scott Phillips, Treasurer and Secretary. Newest notice filed Mar 1, 2019. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Halda Therapeutics, LLC chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Halda Therapeutics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Halda Therapeutics, LLC
NameRoleNamed in
Scott PhillipsExecutive officerAug 2024
Tim ShannonManagerAug 2024
Arjun GoyalManagerAug 2024
Joe CabralManagerAug 2024
Liam RatcliffeManagerAug 2024
Nandita ShangariManagerAug 2024
Rebecca FreyManagerAug 2024
Rebecca LuseManagerAug 2024
Tim ShannonManagerAug 2024
Leyi WangManagerDec 2021
Wei ZhaoManagerMar 2019